University of Pennsylvania: HIV Infections trials

The registry lists 32 HIV Infections studies with University of Pennsylvania as lead sponsor. 0 are open to participants now and 12 have results posted.

Early Phase 1 1Phase 1 8Phase 2 1Phase 3 1Phase 4 2No phase 20(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Tenofovir Rectal Douche to Prevent HIV Transmission Among Adolescents (ATN DREAM)CompletedNCT04686279Phase 1Results posted
• Effect of U=U Messaging on HIV in South AfricaCompletedNCT04364165Not applicableResults posted
• Plan and Pledge, HIV Self-testing in South AfricaCompletedNCT03898557Not applicableResults posted
• Secondary Distribution of HIV Self-tests: an Innovative Strategy for Promoting Partner Testing and Reducing HIV RiskCompletedNCT03135067Not applicableResults posted
• Get Connected Efficacy TrialCompletedNCT03132415Not applicableResults posted
• Puerto Rico Cuidalos Parent-adolescent ProgramCompletedNCT03063385Not applicableResults posted
• Development of a Tailored HIV Prevention Intervention for Young MenCompletedNCT02842060Not applicableResults posted
• Steering Together in a New Direction: Reducing the Risk of HIV/STD Among African American MenCompletedNCT02572401Not applicableResults posted
• Men Together Making a Difference: Reducing HIV/STD Risk Behavior Among South African MenCompletedNCT01490359Not applicableResults posted
• Improving Immunogenicity of Influenza Vaccine in HIV Infected IndividualsCompletedNCT01262846Phase 4Results posted
• H1N1 Influenza Vaccine Immunogenicity in HIV-1 Infected PatientsCompletedNCT01111162Phase 4Results posted
• Efficacy of an Abstinence-Only HIV Risk-Reduction Intervention for Young African-American AdolescentsCompletedNCT00640653Not applicableResults posted
• Digital Community to Improve Health in Rural AreasCompletedNCT05363865Not applicable
• Behavioural Text Messages to Improve Retention in Care in South AfricaCompletedNCT05010291Not applicable
• Acceptability, Feasibility and Impact of Oral HIV Self-testing for Partner Testing Among Kenyan Adolescent Girls Aged 15-19 Years: A Randomized Controlled TrialCompletedNCT04805112Not applicable
• Incentives to Promote Sustained Linkage to HIV CareCompletedNCT04431154Not applicable
• Evaluation of Neuroinflammation FNOS PET/CT in HIV (+) and (-) Subjects With OUD and Healthy ControlsActive, not recruitingNCT04401917Early Phase 1
• Prize-linked Savings Initiatives for Promoting Better Health and Economic Outcomes in KenyaCompletedNCT04013295Not applicable
• Medication Adherence and Outcomes Among Patients in United States With HIVCompletedNCT03995745Not applicable
• A Field Experiment to Assess the Demand for HIV Self-Tests in ZimbabweCompletedNCT03559959Not applicable
• Reality Check: An HIV Risk Reduction Serial DramaCompletedNCT03352219Not applicable
• Being Responsible for Ourselves HIV Risk Reduction for Black MSMCompletedNCT02561286Not applicable
• A Phase I Study of T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728mR in HIV-Infected PatientsCompletedNCT02388594Phase 1
• Pharmacokinetic Characteristics and Anti-Inflammatory Effects of Aprepitant In HIV-Infected SubjectsCompletedNCT02154360Phase 1
• Opioid Relapse & HIV Risk: 48 Versus 24 Weeks of Injectable Extended Release NaltrexoneCompletedNCT01882361Phase 2/3
• Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals. 375 mg DoseCompletedNCT01300988Phase 1
• Pilot Study of Text Message Reminders to Improve HIV Medication Adherence in BotswanaCompletedNCT01001741Not applicable
• Redirected High Affinity Gag-Specific Autologous T Cells for HIV Gene TherapyCompletedNCT00991224Phase 1
• Autologous T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728 for HIVCompletedNCT00842634Phase 1
• PENNVAX-B With or Without IL-12 or IL-15 as a DNA Vaccine for HIV InfectionCompletedNCT00775424Phase 1
• Effects of Treatment With Aprepitant (Emend®) in HIV Infected IndividualsCompletedNCT00428519Phase 1
• Managed Problem Solving to Increase Treatment Adherence in Individuals With HIVCompletedNCT00130273Not applicable